1,000+ Opportunities
Find the right grant
Search federal, foundation, and corporate grants with AI — or browse by agency, topic, and state.
This listing may be outdated. Verify details at the official source before applying.
Find similar grantsParkinson's Research Program (PRP) is sponsored by Congressionally Directed Medical Research Programs (CDMRP). The PRP supports high-impact research to decrease risk, slow progression, or ease symptoms of Parkinson's disease, benefiting service members, veterans, and the general public.
Get a weekly digest of new grants like this
A free weekly digest of new foundation and federal funding opportunities as they're added to Granted. Unsubscribe anytime.
Or search similar grants →Extracted from the official opportunity page/RFP to help you evaluate fit faster.
Parkinson's, Congressionally Directed Medical Research Programs You are using an outdated browser. Please upgrade your browser to improve your experience. U.S. Department of War organization.
Due to routine system maintenance the CDMRP website will be unavailable from COB 24 April - 27 April COB.
DEPARTMENT OF WAR - CONGRESSIONALLY DIRECTED MEDICAL RESEARCH PROGRAMS Transforming Health Care through Innovative and Impactful Research Vision – To improve the health and lives of people with, or at risk for, Parkinson's disease through innovative research that translates to clinically meaningful treatments Mission – To support high-impact research that intends to decrease risk, slow progression, or ease symptoms of Parkinson's disease that benefit Service Members and their Families, Veterans and the general public » Click Image to View Summary Sheet Parkinson's disease (PD) is a degenerative movement disorder of the central nervous system resulting from a loss of neurons in a region of the brain called the substantia nigra.
These neurons produce dopamine, a neurotransmitter important for motor control; however, as PD progresses, the death of dopaminergic neurons results in reduced dopamine levels and impairment of motor control.
For FY22, Congress transitioned the Neurotoxin Exposure Treatment Parkinson's (NETP) program to the Parkinson's Research Program (PRP) and broadened the research from neurotoxin exposure treatment PD research to all types of PD research. The PRP challenges the scientific community to develop the most impactful research that will advance the understanding of the disease, with the ultimate goal of ending PD.
For information on toxic exposure research, please go to the Toxic Exposures Research Program at CDMRP.
Congressional Appropriations Recent Applications Recommended for Funding FY24 Peer Review Participants (pdf) Parkinson's Research Program Booklet FY24 PRP Recommended for Funding List Research Award Recipients The PRP Presents the Fiscal Year 2022 Early Investigator Research Award Recipients 2022 Synergistic Idea Award Recipients Functional and Structural Evidence in the Cortex and the Spinal Cord Neuroplasticity in Parkinson's Disease Physical Therapy Incorporates Digital Health Technology and Behavioral Intervention to Improve Exercise Participation and Slow Down Parkinson's Progression Sarah Keitt: Feeling Empowered Alpha-synuclein: Promising molecular test for Parkinson's disease Click here to provide feedback/comments to the PRP Last updated Thursday, July 16, 2026
According to the current listing, eligibility includes: Not explicitly stated, but generally targets research institutions and scientists. Confirm the full requirements in the official notice before applying.
Parkinson's Research Program (PRP) is funded by Congressionally Directed Medical Research Programs (CDMRP). Verify program details on the funder's official page before applying.
Start from the official opportunity page linked in this listing — it carries the sponsor's submission instructions.
The Congressionally Directed Medical Research Programs just released $1.27 billion across 34 programs. Universities, nonprofits, and small businesses are all eligible.
Read articleCDMRP's FY26 portfolio funds 34 programs, and October 2026 is dense with full-application deadlines: PRCRP October 5, PCRP October 7, MRP October 14. Every one of them is gated behind a pre-application that closed months earlier. Here is what that two-step structure actually costs applicants, and how to be inside the gate for FY27.
Read articleCDMRP reissued the FY26 BCRP Breakthrough Award Levels 1 and 2 and the Clinical Research Extension Award on September 3, 2026, with a November 4 pre-application deadline and a November 18 full application deadline. Round one closed July 8. The arithmetic across both windows accounts for nearly the entire FY26 appropriation — which tells you what kind of second chance this is.
Read article